Online-Only Abstracts  by unknown
Online-Only Abstracts
Temocillin and meropenem to discriminate resistance mechanisms leading to decreased
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Abstract
A temocillin minimal inhibitory concentration  128 mg/L combined with the results of meropenem double disc synergy testing was used
to (i) discriminate carbapenemase production from other resistance mechanisms leading to decreased carbapenem susceptibility; and (ii)
differentiate Ambler classes in carbapenemase-producing enterobacteriaceae (CPE). The suggested test algorithm discriminated all extended
spectrum ß-lactamase/AmpC from CPE isolates, which could further be divided correctly into Ambler classes A and B enzymes as well as
OXA-48 in all cases. The algorithm is simple to implement as part of the daily routine in a standard microbiology laboratory with limited
access to or resources for molecular biological tools.
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Abstract
Two genetically related Klebsiella pneumoniae strains carrying OXA-type carbapenemases were isolated from a single patient 1 month apart.
Kpn163 harboured OXA-163 and Kpn247 a new variant named OXA-247 that showed susceptibility to carbapenems and expanded-
spectrum cephalosporins similar to OXA-48. Our epidemiological, biochemical and molecular results suggest the intrapatient emergence of
blaOXA-247 from blaOXA-163.
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Abstract
We present the ﬁrst case of Raoultella planticola bacteria in human infections with a direct relationship between ﬁsh intake and enteric
infection. The patient was treated with antibiotherapy (cefotaxime). It is important to consider this organism in the differential diagnosis of
enteric fever and even more with previous ingestion of ﬁsh.
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